Answers are grounded in this paper and cite their sources.
In California, molecular testing was useful in decreasing suspicion for severe acute respiratory syndrome (SARS), by detecting common respiratory pathogens (influenza A/B, human metapneumovirus, picornavirus, Mycoplasma pneumoniae, Chlamydia spp., parainfluenza virus, respiratory syncytial virus, and adenovirus) in 23 (45%) of 51 patients with suspected SARS and 9 (47%) of 19 patients with probable SARS.
No takes yet. Share an insight, caveat, or question.
Louie et al. (2004) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: